Protalix Biotherapeutics Inc (PLX) — Cash Flow Quality Index
Protalix Biotherapeutics Inc (PLX) has a Cash Flow Quality Index of 1.85x as of December 2025. Operating cash flow of $2.03 Million exceeds net income of $1.10 Million, indicating high earnings quality where cash backs reported profits. Explore how efficiently does Protalix Biotherapeutics Inc generate cash to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Protalix Biotherapeutics Inc Cash Flow Quality Index (1996–2024)
Historical Cash Flow Quality Index for Protalix Biotherapeutics Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check PLX capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Protalix Biotherapeutics Inc (1996–2024)
Year-by-year earnings quality comparison for Protalix Biotherapeutics Inc. For live market cap and the full company financial profile, see PLX company net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.96x | $8.67 Million | $2.93 Million | ▲ +1965.7% |
| 2023 | -0.16x | $-1.32 Million | $8.31 Million | ▲ +92.4% |
| 1997 | -2.09x | $-247.92K | $118.44K | ▼ -579.4% |
| 1996 | -0.31x | $-40.57K | $131.68K | — |